Back Pain News and Research

RSS
Back pain is a very common problem affecting almost all individuals at some point in their lives. Back pain most commonly affects the lower back although it can be felt anywhere along the spine. An individual may experience aching, tension and stiffness that lasts for only a few days or weeks, or these symptoms may continue for many months or even years.

In most cases, back pain does not have a specific or serious cause and is often referred to as 'non-specific' pain. However, the pain can be triggered or worsened by, for example, a poor sitting or standing posture or bending or lifting incorrectly.

The use of painkillers and keeping active is often sufficient for the condition to resolve within 12 weeks. If back pain lasts longer than this, in which case it is termed chronic pain, an individual should visit their doctor. If the back pain is accompanied by any one of a fever, unexplained weight loss, swelling in the back, chest pain, leg pain, loss of bladder or bowel control, inability to pass urine, or pain that is worse at night, then medical help should be sought immediately. These are termed 'red flag symptoms' and could be a sign of something more serious such as rheumatoid arthritis, a slipped disc or osteoporosis.

People can reduce their chance of developing back pain by engaging in regular exercise, particularly swimming or walking, taking care to bend from the knees and hips rather than the back and maintaining a good posture.
Early physical therapy associated with reduction in opioid use

Early physical therapy associated with reduction in opioid use

People covered by Michigan's expanded Medicaid program report improvements in health, finds study

People covered by Michigan's expanded Medicaid program report improvements in health, finds study

New procedure allows leg length to be precisely adjusted during hip replacement surgery

New procedure allows leg length to be precisely adjusted during hip replacement surgery

FDA approves new drug for treatment of rare autoimmune disorder

FDA approves new drug for treatment of rare autoimmune disorder

Study: Using mobile app to self-assess back pain just as effective as paper methods

Study: Using mobile app to self-assess back pain just as effective as paper methods

Some clinical trials may promote use of ineffective and costly treatments, researchers say

Some clinical trials may promote use of ineffective and costly treatments, researchers say

Survey: Complementary and alternative medicine is widely used by general population in England

Survey: Complementary and alternative medicine is widely used by general population in England

Targeting one brain region with alternating current could decrease symptoms of chronic pain

Targeting one brain region with alternating current could decrease symptoms of chronic pain

Pilates exercise program offers many benefits for people with musculoskeletal conditions

Pilates exercise program offers many benefits for people with musculoskeletal conditions

Study of older women shows link between frequent, persistent back pain and mortality

Study of older women shows link between frequent, persistent back pain and mortality

Researchers develop electroencephalography-based test to objectively measure pain

Researchers develop electroencephalography-based test to objectively measure pain

Almost 60% of truck drivers experience musculoskeletal pain, finds Canadian study

Almost 60% of truck drivers experience musculoskeletal pain, finds Canadian study

Researchers develop new app that reminds users to relax and prevent stress

Researchers develop new app that reminds users to relax and prevent stress

NHS comes up with a list of 20 most painful conditions

NHS comes up with a list of 20 most painful conditions

Effective dose of cannabidiol for safe pain relief without the typical 'high'

Effective dose of cannabidiol for safe pain relief without the typical 'high'

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis